Implications of 3-Year Follow-up Data From the Childhood and Adolescent Migraine Prevention Medication Trial

JAMA Netw Open. 2021 Jul 1;4(7):e2114788. doi: 10.1001/jamanetworkopen.2021.14788.

Authors

Sinifunanya E Nwaobi¹, Joshua Kamins^{1

2}

Affiliations

¹ Goldberg Migraine Program, Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles.
² UCLA Steve Tisch BrainSPORT Program, Department of Neurosurgery, David Geffen School of Medicine at University of California, Los Angeles.

PMID: 34251448
DOI: 10.1001/jamanetworkopen.2021.14788

No abstract available

Publication types

Comment

MeSH terms

Adolescent
Child
Follow-Up Studies
Humans
Migraine Disorders* / drug therapy
Migraine Disorders* / epidemiology
Migraine Disorders* / prevention & control
Research Design